Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    20582937 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed Bortezomib With Chemotherapy for Relapsed Pediatric Acute Lymphoblastic Leukemia (ALL)
Condition: Acute Lymphoblastic Leukemia
Interventions: Drug: bortezomib (Velcade);   Drug: dexamethasone;   Drug: PEG-asparaginase;   Drug: doxorubicin;   Drug: cytarabine;   Drug: methotrexate;   Drug: vincristine

Indicates status has not been verified in more than two years